Thursday, July 20
Moderator: Josh Simmons, MD, FACP
7:30 – 7:40 AM
Genitourinary Cancers
7:40 – 8:05 AM
DEBATE
Adjuvant IO in RCC – Yes vs No
vs
8:05 – 8:25 AM
Biomarker-Based Treatment in Prostate Cancer
8:25 – 8:45 AM
Treatment Updates in Metastatic RCC
8:45 – 9:05 AM
Novel Treatment Options in NMIBC
9:05 – 9:25 AM
Treatment Updates in Metastatic Urothelial Cancer
9:25 – 9:40 AM
Patient-Based Panel Discussion with ASCO Highlights and Q&A
All speakers
Pt case presented by Winship fellow
9:40 – 10:05 AM
Break
Head and Neck
10:05 – 10:20 AM
Novel Systemic Therapy for Head and Neck Cancers
10:20 – 10:40 AM
Updates in Systemic Therapy for Thyroid Cancer
10:40 – 11:00 AM
DEBATE
Surgery Should be Considered the SOC in Low-Risk HPV-Related OPCA – Yes vs No
vs
11:00 – 11:15 AM
Patient-Based Panel Discussion with ASCO Highlights and Q&A
All speakers
Pt case presented by Winship fellow
11:15 – 12:00 PM
Lunch
Moderator: Linda Hendricks, MD
Lymphomas
12:20 – 12:35 PM
How I Evaluate and Treat Patients with Hodgkin Lymphoma
12:35 – 12:50 PM
Novel Therapies for Relapsed T-Cell Lymphoma
12:50 – 1:10 PM
DEBATE
Bi-Specifics vs CAR T-cells in NHL
vs
1:10 – 1:30 PM
Updates in CLL Therapy

1:30 – 1:50 PM

Presentation Title TBC
1:50 – 2:10 PM
Patient-Based Panel Discussion with ASH Highlights and Q&A
All speakers
Pt case presented by Winship fellow
2:10 – 2:15 PM
Closing Comments and Adjourn
6:00 – 8:00 PM
Welcome Dinner at Beach Club

Friday, July 21

Moderator: Eric Turner, MD
7:30 – 7:35 AM
Welcome and Day Overview
Suresh Ramalingam, MD, FASCO
Brain Cancers
7:35 – 7:50 AM
Multidisciplinary Management of Brain Tumors
7:50 – 8:05 AM
Management of GBM
8:05 – 8:20 AM
Management of Primary CNS Lymphoma
8:20 – 8:35 AM
Patient-Based Panel Discussion with ASCO Highlights and Q&A
All speakers
Pt case presented by Winship fellow
Melanoma
8:35 – 8:50 AM
Neoadjuvant and Adjuvant Therapy in Melanoma
8:50 – 9:05 AM
Treatment of PD-1-Refractory Melanoma
9:05 – 9:25 AM
DEBATE
Optimal First-Line Therapy for Newly Diagnosed Metastatic Patients – Nivolumab/Relatlimab vs Nivolumab/Ipilimumab
Jacob S. Choi, MD, PhD
vs
9:25 – 9:50 AM
Break
Leukemia
9:50 – 10:10 AM
Post-Remission Approaches in B-ALL in the Era of Immunotherapy
10:10 – 10:30 AM
DEBATE
Post-transplant Cyclophosphamide Following Allo-HCT is the SOC for Myeloid Neoplasms
vs
10:30 – 10:45 AM
MRD Assessment in Acute Leukemias: How, When, and Really?
10:45 – 11:00 AM
Optimized Use of Targeted Therapeutics in AML
11:00 – 11:15 AM
Treatment Discontinuation in CML
11:15 – 11:30 AM
Patient-Based Panel Discussion with ASH Highlights and Q&A
All speakers
Pt case presented by Winship fellow
11:30 – 12:15 PM
Lunch

Moderator: Frederick Flynt, MD, FACP

Lecture of the Day
12:15 – 12:40 PM
Presentation Title TBC (Global Oncology)
Q&A moderated by Medical Oncology fellow
Gastrointestinal Cancers
12:40 – 12:55 PM
Expanding Treatment Options for Advanced Biliary Tract Cancer
12:55 – 1:10 PM
Current Management of Borderline Resectable/Locally Advanced Pancreatic Cancer
Resectable/Locally Advanced Pancreatic Cancer
1:10 – 1:35 PM
DEBATE
Early-Stage MSI-H Rectal Cancer: Surgery First vs IO First
vs
1:35 – 1:50 PM
Updates in Metastatic Colon Cancer

1:50 – 2:10 PM

Patient-Based Panel Discussion with ASCO Highlights and Q&A
All speakers
Pt case presented by Winship fellow
2:10 – 2:15 PM
Closing Comments and Adjourn

Saturday, July 22

Moderator: Michael Andrews, MD

8:00 – 8:05 AM
Welcome and Day Overview
Thoracic Cancers
8:05 – 8:20 AM
Targeted Therapy in 2023
8:20 – 8:40 AM
DEBATE
Neoadjuvant vs Adjuvant Therapy in Resectable NSCLC
vs
8:40 – 8:55 AM
Advances in Small Cell Lung Cancer Therapy
8:55 – 9:10 AM
New Era of Perioperative Therapy in NSCLC
9:10 – 9:25 AM
What is New in IO Therapy in Advanced NSCLC
9:25 – 9:40 AM
Evolving Landscape of Stage III NSCLC
9:40 – 10:00 AM
Patient-based Panel Discussion with ASCO Highlights and Q&A
All speakers
Pt case presented by Winship fellow
10:00 – 10:20 AM
Break
Gynecologic Cancers
10:20 – 10:30 AM
The ABCs of ADCs in Ovarian Cancer
10:30 – 10:45 AM
Updates on Targeted Therapies, ADCs, and Immunotherapy for Advanced or Recurrent Cervical Cancer
10:45 – 11:05 AM
DEBATE
The Age of Radiation is OVER in Advanced Endometrial Cancer with the Advent of Combined Chemotherapy and Immunotherapy: Yes vs No
vs
Lecture of the Day
11:05 – 11:30 AM
Presentation Title TBC (Broad Myeloma)
Q&A moderated by Medical Oncology fellow
11:30 – 12:15 PM
Lunch

Moderator: Sarah Friend, MD

Myeloma
12:15 – 12:35 PM
Smoldering Myeloma – Who Will Need Early Treatment vs Watchful Waiting?
12:35 – 12:55 PM
DEBATE
Early vs Deferred Transplant in MM
vs
12:55 – 1:15 PM
Novel Combination Therapies in Upfront Treatments – Evidence for Quadruplets
1:15 – 1:35 PM
DEBATE
Who is the Right Patient for CART vs Bispecific Antibodies?
vs
1:35 – 1:55 PM
Waldenstrom’s Macroglobulinemia – Approach to Diagnosis and Treatment
1:55 – 2:10 PM
Patient-based Panel Discussion with ASH Highlights and Q&A
All speakers
Pt case presented by Winship fellow
2:10 – 2:15 PM
Closing Comments and Adjourn
5:00 – 6:30 PM
Closing Reception at Beach Club

Sunday, July 23

Moderator: Melissa Dillmon, MD
8:00 – 8:05 AM
Welcome and Day Overview
Breast Cancer
8:05 – 8:25 AM
Surgical Therapy in the Setting of Metastatic Breast Cancer
8:25 – 8:45 AM
DEBATE
Stereotactic Body Radiation Therapy for Oligometastatic Breast Cancer
vs
8:45 – 9:05 AM
Evolving Landscape in HR+/HER2- Metastatic Breast Cancer
9:05 – 9:25 AM
Updates in HER2+ Breast Cancer
9:25 – 9:45 AM
DEBATE
Are all CDK4/6 Inhibitors the Same? Yes vs No
vs
9:45 – 10:05 AM
Metastatic Triple Negative Breast Cancer: Sequencing Immunotherapy, PARP Inhibitors, and Antibody-Drug Conjugates
10:05 – 10:25 AM
Patient-based Panel Discussion with ASCO Highlights and Q&A
All speakers
Pt case presented by Winship fellow
10:25 – 10:30 AM